K+S (0Q2N) Stock Overview
Operates as a supplier of mineral products for the agricultural, industrial, pharma, consumer, and community sectors in Europe, Germany, North America, South America, Asia, Africa, and Oceania. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0Q2N from our risk checks.
0Q2N Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
K+S Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €15.53 |
| 52 Week High | €18.67 |
| 52 Week Low | €10.40 |
| Beta | 0.27 |
| 1 Month Change | 6.03% |
| 3 Month Change | 7.32% |
| 1 Year Change | 1.28% |
| 3 Year Change | -7.69% |
| 5 Year Change | 57.42% |
| Change since IPO | -50.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0Q2N | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 1.1% | -1.2% | -0.7% |
| 1Y | 1.3% | 9.0% | 17.0% |
Return vs Industry: 0Q2N underperformed the UK Chemicals industry which returned 9% over the past year.
Return vs Market: 0Q2N underperformed the UK Market which returned 17% over the past year.
Price Volatility
| 0Q2N volatility | |
|---|---|
| 0Q2N Average Weekly Movement | 8.0% |
| Chemicals Industry Average Movement | 7.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in GB Market | 12.0% |
| 10% least volatile stocks in GB Market | 3.1% |
Stable Share Price: 0Q2N has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0Q2N's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1889 | 11,261 | Christian Meyer | www.kpluss.com |
K+S Aktiengesellschaft, together with its subsidiaries, operates as a supplier of mineral products for the agricultural, industrial, pharma, consumer, and community sectors in Europe, Germany, North America, South America, Asia, Africa, and Oceania. The company offers potassium chloride for crops, such as grain, corn, rice, soybeans, and sugar cane; fertilizer specialties that are used for crops with magnesium and sulfur requirements, including rapeseed, sugar beet, and potatoes, as well as for chloride-sensitive specialty crops such as citrus, grapes, coffee, almond trees, and vegetables; and water-soluble fertilizers for use in fertigation of fruit and vegetables under the KALISOP, KORN-KALI, ROLLKALI, PATENTKALI, ESTA KIESERIT, GRANUAID, MAGNESIA-KAINIT, SOLUMOP, SOLUSOP, SOLUCMS, EPSO TOP, EPSO MICROTOP, EPSO COMBITOP, EPSO PROFITOP, and EPSO BORTOP brands. It also provides soil, fertigation, foliar fertilizers, natural rock salt, high-purity vaccum salt and mineral salt mixtures, potassium chloride, potassium sulphate, Epsom salt, minerals for pets and livestock, potassium, magnesium, salt, salt licks for farm and wild animals, sodium chloride, salt tablets, and vacuum salt granules under the k-DRILL, KaSa, SOLSEL, NUTRIKS, AXAL PRO, REGINET, Regesal, Marina, Marina Plus, Solea, and APISAL brands.
K+S Aktiengesellschaft Fundamentals Summary
| 0Q2N fundamental statistics | |
|---|---|
| Market cap | €2.77b |
| Earnings (TTM) | -€1.32b |
| Revenue (TTM) | €3.74b |
Is 0Q2N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0Q2N income statement (TTM) | |
|---|---|
| Revenue | €3.74b |
| Cost of Revenue | €5.04b |
| Gross Profit | -€1.30b |
| Other Expenses | €21.30m |
| Earnings | -€1.32b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Aug 12, 2026
| Earnings per share (EPS) | -7.36 |
| Gross Margin | -34.64% |
| Net Profit Margin | -35.21% |
| Debt/Equity Ratio | 10.5% |
How did 0Q2N perform over the long term?
See historical performance and comparisonDividends
Does 0Q2N pay a reliable dividends?
See 0Q2N dividend history and benchmarks| K+S dividend dates | |
|---|---|
| Ex Dividend Date | May 13 2026 |
| Dividend Pay Date | May 18 2026 |
| Days until Ex dividend | 5 days |
| Days until Dividend pay date | 0 days |
Does 0Q2N pay a reliable dividends?
See 0Q2N dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/17 19:26 |
| End of Day Share Price | 2026/05/15 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
K+S Aktiengesellschaft is covered by 42 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephen Wilder | Alliance Global Partners |
| Knut Woller | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |